Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год
Применить Всего найдено 19. Отображено 17.
31-10-2017 дата публикации

Oxygen-enabled fluid

Номер: US0009801906B2
Автор: Erica D. Bruce, Christie Sayes, John W. Woodmansee, Jr., BRUCE ERICA D, SAYES CHRISTIE, WOODMANSEE JR JOHN W, Bruce Erica D., Sayes Christie, Woodmansee, Jr. John W.
Принадлежит: Baylor University, UNIV BAYLOR

A colloid or crystalline solution with the addition of poly-oxygenated metal hydroxide particles. The solution is configured to treat a condition of a mammal, including a human individual and an animal including a depletion of hemoglobin and hemorrhagic shock. The solution can be intravenously administered. In some embodiments, the poly-oxygenated metal hydroxide is an aluminum poly-oxygenated hydroxide, such as Ox66™. The poly-oxygenated metal hydroxide may have particles having a diameter of less than or equal to 1 um, and specifically having a diameter of less than or equal to 100 nm.

Подробнее
Номер записи: 1
16-05-2017 дата публикации

Intravenous administration of an oxygen-enabled fluid

Номер: US0009649335B1
Автор: Erica D. Bruce, Christie Sayes, John W. Woodmansee, Jr., BRUCE ERICA D, SAYES CHRISTIE, WOODMANSEE JR JOHN W, Bruce Erica D., Sayes Christie, Woodmansee, Jr. John W.
Принадлежит: Baylor University, UNIV BAYLOR

A method of treating a condition of a mammal, including a human individual and an animal, by intravenously administering a therapeutically effective amount of a poly-oxygenated metal hydroxide. In some embodiments, the poly-oxygenated metal hydroxide is an aluminum poly-oxygenated hydroxide, such as Ox66™. The poly-oxygenated metal hydroxide may have particles having a diameter of less than or equal to 1 um, and specifically having a diameter of less than or equal to 100 nm. The poly-oxygenated metal hydroxide may be 75-90% colloid or crystalline solution with 10-25% addition of poly-oxygenated metal hydroxide particles.

Подробнее
Номер записи: 2
05-10-2017 дата публикации

Oxygen-Enabled Fluid

Номер: US20170281675A1
Автор: Erica D. Bruce, Christie SAYES, John W. WOODMANSEE, JR., BRUCE ERICA D, SAYES CHRISTIE, WOODMANSEE JR JOHN W, Bruce Erica D., SAYES Christie, WOODMANSEE, JR. John W.
Принадлежит:

A colloid or crystalline solution with the addition of poly-oxygenated metal hydroxide particles. The solution is configured to treat a condition of a mammal, including a human individual and an animal including a depletion of hemoglobin and hemorrhagic shock. The solution can be intravenously administered. In some embodiments, the poly-oxygenated metal hydroxide is an aluminum poly-oxygenated hydroxide, such as Ox66™. The poly-oxygenated metal hydroxide may have particles having a diameter of less than or equal to 1 um, and specifically having a diameter of less than or equal to 100 nm. 1. An oxygen enabled solution , comprising:a fluid; and{'sub': '2', 'a poly-oxygenated metal hydroxide material solubilized in the fluid and forming a colloid or crystalline solution, wherein the poly-oxygenated metal hydroxide material comprises a clathrate compound having free Ogas molecules.'}2. The oxygen enabled solution as specified in wherein the poly-oxygenated metal hydroxide material is dissolved in the fluid and also retains its integrity.3. The oxygen enabled solution as specified in wherein the solution is a 75-90% colloid or crystalline solution with 10-25% addition of the poly-oxygenated metal hydroxide material.4. The oxygen enabled solution as specified in wherein the solution is a 75-90% colloid with 10-25% addition of the poly-oxygenated metal hydroxide material.5. The oxygen enabled solution as specified in wherein the fluid is phosphate buffered saline (PBS).6. The oxygen enabled solution as specified in wherein the fluid is a lactated Ringers solution (LRS).7. The oxygen enabled solution as specified in wherein the solution is a 75-90% crystalline solution with 10-25% addition of the poly-oxygenated metal hydroxide material.8. The oxygen enabled solution as specified in wherein the fluid is phosphate buffered saline (PBS).9. The oxygen enabled solution as specified in wherein the solution has a concentration range of 0.1 mg/l to 1000 mg/l.10. The oxygen enabled ...

Подробнее
Номер записи: 3
20-06-2017 дата публикации

Administration of a poly-oxygenated metal hydroxide to reduce the proliferation of carcinoma cells

Номер: US0009682103B1
Автор: Erica D. Bruce, Christie Sayes, John W. Woodmansee, Jr., BRUCE ERICA D, SAYES CHRISTIE, WOODMANSEE JR JOHN W, Bruce Erica D., Sayes Christie, Woodmansee, Jr. John W.
Принадлежит: Baylor University, UNIV BAYLOR

A method of treating a condition of a mammal, including a human individual and an animal, by intravenously administering a therapeutically effective amount of a poly -oxygenated metal hydroxide. In some embodiments, the poly-oxygenated metal hydroxide is an aluminum poly-oxygenated hydroxide, such as Ox66™. The poly-oxygenated metal hydroxide may have particles having a diameter of less than or equal to 1 um, and specifically having a diameter of less than or equal to 100 nm. The poly-oxygenated metal hydroxide may be 75-90% colloid or crystalline solution with 10-25% addition of poly-oxygenated metal hydroxide particles.

Подробнее
Номер записи: 4
27-02-2020 дата публикации

Method of Treating Diaper Rash with a Poly-Oxygenated Metal Hydroxide

Номер: US20200061232A1
Автор: Bruce Erica D., JR. John W., Woodmansee
Принадлежит:

An oxygen impregnated material suitable for an oxygenating therapeutic to treat wounds with oxygen. The impregnated material avoids the applicational complications associated with conventional oxygen therapeutics, such as reliance on gaseous oxygen, systemic toxicity, and patient immobility. This impregnated material can be used, for example, in bandage-type dressings, or a drape of a vacuum-assisted closure (VAC). This impregnated material can also be used in a diaper to treat and reduce the formation of a rash on the skin. 1. A method , comprising:applying a diaper to a user, the diaper comprising a material impregnated with a poly-oxygenated aluminum hydroxide comprising a clathrate containing oxygen gas molecules, to treat and reduce the formation of a diaper rash on skin.2. The method as specified in wherein the poly-oxygenated aluminum hydroxide is configured to reduce ammonia within the diaper.3. The method as specified in wherein the poly-oxygenated aluminum hydroxide is soluble. This application is a Divisional of U.S. patent application Ser. No. 16/287,735 filed Feb. 27, 2019, which is a Continuation-in-Part (CIP) of U.S. patent application Ser. No. 15/983,922 entitled REDUCING THE PROLIFERATION OF CARCINOMA CELLS BY ADMINISTRATION OF A POLY-OXYGENATED METAL HYDROXIDE, which is a Continuation-in-Part (CIP) of U.S. patent application Ser. No. 15/797,972 filed Oct. 30, 2017, entitled REDUCING THE PROLIFERATION OF CARCINOMA CELLS BY ADMINISTRATION OF A POLY-OXYGENATED METAL HYDROXIDE, which is a Continuation-in-Part (CIP) of U.S. patent application Ser. No. 15/183,403 filed Jun. 15, 2016, entitled INTRAVENOUS ADMINISTRATION OF AN OXYGEN-ENABLE FLUID, which claims priority of U.S. Provisional Patent Application Ser. No. 62/315,524 entitled OXYGEN-ENABLED RESUSCITATIVE FLUID filed Mar. 30, 2016, the teachings of which are incorporated herein by reference in their entirety.This disclosure is directed to an impregnated material for providing wound care to a ...

Подробнее
Номер записи: 5
15-03-2018 дата публикации

Reducing the proliferation of carcinoma cells by administration of a poly-oxygenated metal hydroxide

Номер: US20180071334A1
Автор: Christie SAYES, Erica D. Bruce, John W. Woodmansee, JR.
Принадлежит: BAYLOR UNIVERSITY

A colloid or crystalline solution with the addition of poly-oxygenated metal hydroxide particles. The solution is configured to treat a condition of a mammal, including a human individual and an animal, including a depletion of hemoglobin and hemorrhagic shock. The solution can be intravenously administered. In some embodiments, the poly-oxygenated metal hydroxide is an aluminum poly-oxygenated hydroxide, such as O×66™. The poly-oxygenated metal hydroxide may have particles having a diameter of less than or equal to 1 um, and specifically having a diameter of less than or equal to 100 nm.

Подробнее
Номер записи: 6
20-09-2018 дата публикации

REDUCING THE PROLIFERATION OF CARCINOMA CELLS BY ADMINISTRATION OF A POLY-OXYGENATED METAL HYDROXIDE

Номер: US20180264034A1
Автор: Bruce Erica D., JR. John W., Woodmansee
Принадлежит:

A method of treating a mammal, comprising administering a therapeutically effective amount of a poly-oxygenated metal hydroxide composition to a mammal to reduce a proliferation of hypoxic carcinoma cells, wherein the poly-oxygenated metal hydroxide composition comprises a clathrate containing free oxygen gas (O) molecules. The carcinoma cells may comprise prostrate carcinoma (22Rv1). The poly-oxygenated metal hydroxide material is configured to provide bioavailable oxygen gas molecules to a mammal when administered to the mammal. The poly-oxygenated metal hydroxide composition can be administered intravenously, directly to carcinoma cells, and orally. The composition may comprise a fluid, where the poly-oxygenated metal hydroxide composition is soluble in the fluid. 1. A method of treating a mammal , comprising:{'sub': '2', 'administering a therapeutically effective amount of a poly-oxygenated metal hydroxide composition to a mammal to reduce a proliferation of hypoxic carcinoma cells, wherein the poly-oxygenated metal hydroxide composition comprises a clathrate containing free oxygen gas (O) molecules.'}2. The method as specified in wherein the carcinoma cells comprise prostrate carcinoma (22Rv1).3. The method as specified in wherein the poly-oxygenated metal hydroxide material is configured to provide bioavailable oxygen gas molecules to a mammal when administered to the mammal.4. The method as specified in wherein the poly-oxygenated metal hydroxide composition is administered intravenously.5. The method as specified in wherein the poly-oxygenated metal hydroxide composition is administered directly to the hypoxic carcinoma cells.6. The method as specified in wherein the poly-oxygenated metal hydroxide composition is administered orally.7. The method as specified in wherein the composition comprises a fluid.8. The method as specified in wherein the poly-oxygenated metal hydroxide composition is soluble in the fluid.9. The method as specified in wherein the fluid ...

Подробнее
Номер записи: 7
20-09-2018 дата публикации

REDUCING THE PROLIFERATION OF ADENOCARCINOMA CELLS (CACO-2) BY ADMINISTRATION OF A POLY-OXYGENATED METAL HYDROXIDE

Номер: US20180264035A1
Автор: Bruce Erica D., JR. John W., Woodmansee
Принадлежит:

A method of treating a mammal, comprising administering a therapeutically effective amount of a poly-oxygenated metal hydroxide composition to a mammal to reduce a proliferation of hypoxic carcinoma cells, wherein the poly-oxygenated metal hydroxide composition comprises a clathrate containing free oxygen gas (O) molecules. The carcinoma cells may comprise colon adenocarcinoma cells (CaCo-2). The poly-oxygenated metal hydroxide material is configured to provide bioavailable oxygen gas molecules to a mammal when administered to the mammal. The poly-oxygenated metal hydroxide composition can be administered intravenously, directly to carcinoma cells, and orally. The composition may comprise a fluid, where the poly-oxygenated metal hydroxide composition is soluble in the fluid. 1. A method of treating a mammal , comprising:{'sub': '2', 'administering a therapeutically effective amount of a poly-oxygenated metal hydroxide composition to a mammal to reduce a proliferation of colon adenocarcinoma cells (CaCo-2), wherein the poly-oxygenated metal hydroxide composition comprises a clathrate containing free oxygen gas (O) molecules.'}2. The method as specified in wherein the poly-oxygenated metal hydroxide material is configured to provide bioavailable oxygen gas molecules to a mammal when administered to the mammal.3. The method as specified in wherein the poly-oxygenated metal hydroxide composition is administered intravenously.4. The method as specified in wherein the poly-oxygenated metal hydroxide composition is administered directly to the colon adenocarcinoma cells (CaCo-2).5. The method as specified in wherein the poly-oxygenated metal hydroxide composition is administered orally.6. The method as specified in wherein the composition comprises a fluid.7. The method as specified in wherein the poly-oxygenated metal hydroxide composition is soluble in the fluid.8. The method as specified in wherein the fluid is a phosphate buffered saline (PBS).9. The method as ...

Подробнее
Номер записи: 8
29-08-2019 дата публикации

Wound dressing including a poly-oxygenated metal hydroxide

Номер: US20190262495A1
Автор: Erica D. Bruce, John W. Woodmansee, JR.
Принадлежит: BAYLOR UNIVERSITY

An oxygen impregnated material suitable for an oxygenating therapeutic to treat wounds with oxygen. The impregnated material avoids the applicational complications associated with conventional oxygen therapeutics, such as reliance on gaseous oxygen, systemic toxicity, and patient immobility. This impregnated material can be used, for example, in bandage-type dressings, or a drape of a vacuum-assisted closure (VAC). This impregnated material can also be used in a diaper to treat and reduce the formation of a rash on the skin.

Подробнее
Номер записи: 9
27-09-2018 дата публикации

OXYGEN-ENABLED COMPOSITION

Номер: US20180271899A1
Автор: Bruce Erica D, JR. John W, Woodmansee, Woodmansee Robert A
Принадлежит:

A composition of chlorine-free poly-oxygenated metal hydroxide that comprises a clathrate containing oxygen gas molecules, and which may comprise a nutraceutical. In one embodiment, the poly-oxygenated metal hydroxide composition is soluble, and may have particles having a diameter of 212 μm or less. The poly-oxygenated metal hydroxide may comprise of a poly-oxygenated aluminum hydroxide. The nutraceutical may include one or more of a protein, vitamin, fiber, mineral and electrolytes. The composition may be in a powder or fluid form, where the poly-oxygenated aluminum hydroxide is soluble in the fluid. 1. A composition , comprising:a poly-oxygenated aluminum hydroxide comprising a clathrate containing oxygen gas molecules that is chlorine-free and soluble in a fluid.2. The composition as specified in claim 1 , further comprising a nutraceutical selected from the group of protein claim 1 , a vitamin claim 1 , fiber claim 1 , and electrolytes.3. The composition as specified in claim 1 , wherein the poly-oxygenated aluminum hydroxide comprises particles each having a diameter of less than or equal to 212 μm.4. The composition as specified in claim 3 , wherein the poly-oxygenated aluminum hydroxide is homogeneous.5. The composition as specified in claim 1 , wherein the poly-oxygenated aluminum hydroxide is configured to be orally delivered and absorbed through lining of a stomach and a small intestine of a mammal.6. The composition as specified in claim 1 , wherein poly-oxygenated aluminum hydroxide is configured to be therapeutically effective in treating a condition of a mammal.7. The composition as specified in claim 1 , further comprising a fluid having a concentration of at least 1 milligram of the poly-oxygenated aluminum hydroxide to 8 fluid ounces of the fluid.8. (canceled)9. The composition as specified in claim 1 , wherein the poly-oxygenated aluminum hydroxide is configured to not create an response of the mammal.10. The composition as specified in claim 1 , ...

Подробнее
Номер записи: 10
27-09-2018 дата публикации

REDUCING THE PROLIFERATION OF LUNG CARCINOMA CELLS (A549) BY ADMINISTRATION OF A POLY-OXYGENATED METAL HYDROXIDE

Номер: US20180271900A1
Автор: Bruce Erica D., Woodmansee John W.
Принадлежит:

A method of treating a mammal, comprising administering a therapeutically effective amount of a poly-oxygenated metal hydroxide composition to a mammal to reduce a proliferation of hypoxic carcinoma cells, wherein the poly-oxygenated metal hydroxide composition comprises a clathrate containing free oxygen gas (O) molecules. The carcinoma cells may comprise lung carcinoma (A549). The poly-oxygenated metal hydroxide material is configured to provide bioavailable oxygen gas molecules to a mammal when administered to the mammal. The poly-oxygenated metal hydroxide composition can be administered intravenously, directly to carcinoma cells, and orally. The composition may comprise a fluid, where the poly-oxygenated metal hydroxide composition is soluble in the fluid. 1. A method of treating a mammal , comprising:{'sub': '2', 'administering a therapeutically effective amount of a poly-oxygenated metal hydroxide composition to a mammal to reduce a proliferation of lung carcinoma cells (A549), wherein the poly-oxygenated metal hydroxide composition comprises a clathrate containing free oxygen gas (O) molecules.'}2. The method as specified in wherein the poly-oxygenated metal hydroxide material is configured to provide bioavailable oxygen gas molecules to a mammal when administered to the mammal.3. The method as specified in wherein the poly-oxygenated metal hydroxide composition is administered intravenously.4. The method as specified in wherein the poly-oxygenated metal hydroxide composition is administered directly to the lung carcinoma cells.5. The method as specified in wherein the poly-oxygenated metal hydroxide composition is administered orally.6. The method as specified in wherein the composition comprises a fluid.7. The method as specified in wherein the poly-oxygenated metal hydroxide composition is soluble in the fluid.8. The method as specified in wherein the fluid is a phosphate buffered saline (PBS).9. The method as specified in wherein the fluid is lactated ...

Подробнее
Номер записи: 11
05-10-2017 дата публикации

Process For Generating Nanometer Sized Particles That Increase Oxygen Levels In Mammalian Tissues

Номер: US20170281674A1
Автор: Bruce Erica D., JR. John W., SAYES Christie, Woodmansee
Принадлежит:

A composition and process to produce poly-oxygenated metal hydroxide particles on the nanometer size scale. The relevant particle size includes all size populations ranging from 1 nanometer (nm) to 3000 nanometers (nm) or 3 micrometer (μm) in particle diameter. Filtering may be used to create homogeneous particle sizes. Exemplary delivery applications include inhalation, ingestion, anally, vaginally, dermal penetration or permeation, intramuscular injection, and intravenous injection to treat numerous conditions and diseases of mammals, including humans and animals. 1. A process for generating reduced sized particles of poly-oxygenated metal hydroxide , comprising the step of:obtaining predetermined quantity of poly-oxygenated metal hydroxide material;determining process variables as a function of the predetermined quantity; andprocessing the predetermined quantity of poly-oxygenated metal hydroxide material using the determined process variables to create a processed quantity poly-oxygenated metal hydroxide material having particle sizes of less than or equal to 3 μm in diameter.2. The process as specified in wherein the processed quantity of oxygenated metal hydroxide material is homogenous.3. The process as specified in claim 1 , further comprising the step of:analyzing the processed quantity of poly-oxygenated metal hydroxide material to confirm the particle sizes are less than or equal to 3 μm in diameter.4. The process as specified in further comprising the step of using a planetary motion machine to perform the processing step.5. The process as specified in wherein the process variables are determined based on a milling scale.6. The process as specified in wherein the poly-oxygenated metal hydroxide material comprises a poly-oxygenated aluminum hydroxide.7. The process as specified in wherein the processing step creates a homogenous quantity of poly-oxygenated metal hydroxide material having particle sizes of less than or equal to 250 nm diameter.8. A ...

Подробнее
Номер записи: 12
26-10-2017 дата публикации

NUTRACEUTICAL CONTAINING AN OXYGEN-ENABLED COMPOSITION

Номер: US20170304357A1
Автор: Bruce Erica D, JR. John W, Woodmansee, Woodmansee Robert A
Принадлежит:

A composition of chlorine-free poly-oxygenated aluminum hydroxide that comprises a clathrate containing oxygen gas molecules and a nutraceutical. In one embodiment, the poly-oxygenated aluminum hydroxide has particles having a diameter of 212 μm or less. The nutraceutical may include one or more of a protein, vitamin, fiber, mineral and electrolytes. The composition may be in a powder or fluid form. 1. A composition , comprising:a poly-oxygenated aluminum hydroxide comprising a clathrate containing oxygen gas molecules that is chlorine-free; anda nutraceutical.2. The composition as specified in claim 1 , wherein the nutraceutical is selected from the group of a protein claim 1 , a vitamin claim 1 , fiber claim 1 , and electrolytes.3. The composition as specified in claim 1 , wherein the poly-oxygenated aluminum hydroxide comprises particles each having a diameter of less than or equal to 212 μm .4. The composition as specified in wherein the poly-oxygenated aluminum hydroxide is configured to be orally delivered and absorbed through lining of a stomach and a small intestine of a mammal.5. The composition as specified in wherein poly-oxygenated aluminum hydroxide is configured to be therapeutically effective in treating a condition of a mammal.6. The composition as specified in further comprising a fluid having a concentration of at least 1 milligram of the poly-oxygenated aluminum hydroxide to 8 fluid ounces of the fluid.7. The composition as specified in claim 2 , wherein the poly-oxygenated aluminum hydroxide is homogeneous.8. The composition as specified in wherein the poly-oxygenated aluminum hydroxide is configured to not create an immune response of the mammal.9. The composition as specified in claim 1 , wherein the particles each have a diameter in the range of 107-212 um.10. The composition as specified in claim 1 , wherein the particles each have a diameter in the range of 46-106 um.11. The composition as specified in claim 1 , wherein the particles each ...

Подробнее
Номер записи: 13
27-11-2018 дата публикации

Oxygen-enabled composition

Номер: US10137146B2
Автор: Erica D Bruce, John W Woodmansee, JR., Robert A Woodmansee
Принадлежит: BAYLOR UNIVERSITY

A composition of chlorine-free poly-oxygenated metal hydroxide that comprises a clathrate containing oxygen gas molecules, and which may comprise a nutraceutical. In one embodiment, the poly-oxygenated metal hydroxide composition is soluble, and may have particles having a diameter of 212 μm or less. The poly-oxygenated metal hydroxide may comprise of a poly-oxygenated aluminum hydroxide. The nutraceutical may include one or more of a protein, vitamin, fiber, mineral and electrolytes. The composition may be in a powder or fluid form, where the poly-oxygenated aluminum hydroxide is soluble in the fluid.

Подробнее
Номер записи: 14
13-03-2019 дата публикации

Solution comprising poly-oxygenated metal hydroxide

Номер: EP3452059A1
Автор: Christie SAYES, Erica D. Bruce, John W. Woodmansee, JR.
Принадлежит: BAYLOR UNIVERSITY

A colloid or crystalline solution with the addition of a poly-oxygenated metal hydroxide comprising a clathrate compound having free O2 gas molecules. The oxygen enabled solution is configured to oxygenate the interstitial tissue of a mammal, such as a mammal having depleted PISF O2 suffering from severe blood loss and/or experiencing hemorrhagic shock. The solution can be intravenously administered. In some embodiments, the poly-oxygenated metal hydroxide is an aluminum poly-oxygenated hydroxide. The poly-oxygenated metal hydroxide may have particles having a diameter of less than or equal to 1 um, and specifically having a diameter of less than or equal to 100 nm.

Подробнее
Номер записи: 15
05-10-2017 дата публикации

Solution comprising poly-oxygenated metal hydroxide

Номер: WO2017172898A1
Автор: Christie SAYES, Erica D. Bruce, John W. Woodmansee, JR.
Принадлежит: BAYLOR UNIVERSITY

A colloid or crystalline solution with the addition of a poly-oxygenated metal hydroxide comprising a clathrate compound having free O 2 gas molecules. The oxygen enabled solution is configured to oxygenate the interstitial tissue of a mammal, such as a mammal having depleted P ISF O 2 suffering from severe blood loss and/or experiencing hemorrhagic shock. The solution can be intravenously administered. In some embodiments, the poly-oxygenated metal hydroxide is an aluminum poly-oxygenated hydroxide. The poly-oxygenated metal hydroxide may have particles having a diameter of less than or equal to 1 um, and specifically having a diameter of less than or equal to 100 nm.

Подробнее
Номер записи: 16
24-04-2018 дата публикации

Nutraceutical containing an oxygen-enabled composition

Номер: US09950006B2
Автор: Erica D Bruce, John W Woodmansee, JR., Robert A Woodmansee
Принадлежит: BAYLOR UNIVERSITY

A composition of chlorine-free poly-oxygenated aluminum hydroxide that comprises a clathrate containing oxygen gas molecules and a nutraceutical. In one embodiment, the poly-oxygenated aluminum hydroxide has particles having a diameter of 212 μm or less. The nutraceutical may include one or more of a protein, vitamin, fiber, mineral and electrolytes. The composition may be in a powder or fluid form.

Подробнее
Номер записи: 17